Characterization of bacteriophages with specific for antibiotic-resistant <em>Salmonella </em>Typhimurium — ASN Events

Characterization of bacteriophages with specific for antibiotic-resistant Salmonella Typhimurium (#231)

Maheswaran Easwaran , Juhee Ahn

Bacteriophage has received renewed attention as an alternative treatment for antibiotic-resistant bacterial infections. This study aimed to investigate the possibility of using bacteriophages in controlling antibiotic-resistant Salmonella Typhimurium. The bacteriophages were characterized by phage adsorption, lytic activity, and specificity against S. Typhimurium KCCM 40253 (STKCCM), S. Typhimurium ATCC 19585 (STWT), ciprofloxacin-induced antibiotic-resistant S. Typhimurium ATCC 19585 (STCIP), and S. Typhimurium CCARM 8009 (STCCARM). The host ranges of phages, P22 and PBST-35, were narrow and specific to STKCCM. The highest rates of P22 adsorption were 78%, 76%, and 90%, respectively, against STKCCM, STWT, and STCIP, while the lowest adsorption rate was observed in STCCARM (73%). The latent period of P22 was 20 min against STWT and STCIP, having burst sizes of 250 and 514 PFU/cell. Respectively, at MOI of 1. The highest lytic activity of P22 was observed against STKCCM, STWT, and STCIP at 12 h post-infection. No noticeable lytic activity was observed against STCCARM. The results would provide useful information for better understanding the phage specificity for antibiotic-resistant pathogens.

  1. Park, D.J., Drobniewski, F.A., Meyer, A. and Wilson, S.M. (2003) Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J Clin Microbiol, 680–688. Nat Rev Microbiol 8, 260–271.
  2. Kim, J., Jo, A., Ding, T., Lee, H.Y. and Ahn, J. (2016) Assessment of altered binding specificity of bacteriophage for ciprofloxacin‑induced antibiotic‑resistant Salmonella Typhimurium. Arch Microbiol 198, 521–529.
  3. Jung, L.S. Ding, T. and Ahn, J. (2017) Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium. Ann Clin Microbiol Antimicrob, 16:66.
#2018ASM